4BASEBIO PLC EO 1
Research 4BASEBIO PLC EO 1 (88Q) on Bullrun: market cap EUR 92.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker88Q
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 92.91M
- Financial periodFY2024
- RevenueEUR 933.00K
- Revenue growth84.4%
- Net income-EUR 12.33M
- Free cash flow-EUR 12.32M
- Gross margin67.5%
Valuation Snapshot
latest market cap is EUR 92.91M.
About 4BASEBIO PLC EO 1
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA for in vitro transcription processes that produce mRNA for use in vaccines and therapeutics; oeDNA, a linear, double stranded DNA for genome editing;
Frequently asked questions
What is 4BASEBIO PLC EO 1's market cap?
4BASEBIO PLC EO 1's market capitalization is EUR 92.91M.
What does 4BASEBIO PLC EO 1 do?
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double stranded linear DNA for viral and non-viral vector applications;